TVTX TRAVERE THERAPEUTICS INC Earnings Reports 8-K Filing 2024 - Financial Results Travere Therapeutics, Inc. filed a letter mentioning their financial results for the second quarter of 2021, reporting a net loss of $45.7 million.Get access to all SEC 8-K filings of the TRAVERE THERAPEUTICS INC